Capsa Healthcare Acquires Tryten Technologies to Strengthen Its Leadership Position in Mobile Computing
COLUMBUS, Ohio, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Tryten Technologies Inc., a designer and manufacturer of lightweight, easy to maneuver mobile cart solutions. Tryten is based in Langley, British Columbia.
A Media Snippet accompanying this announcement is available by clicking the image or link below.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
Capsa’s purchase of Tryten is the company’s second major brand acquisition in the last year, and strategically addresses several healthcare industry trends. Today’s hospitals and clinics are striving to provide expanded virtual care, improved patient engagement and efficient mobility for small medical devices; Capsa now has the widest product portfolio to support these needs.
Tryten is an industry leader known for thoughtful, simple, slim-profile cart designs to support virtual care and improved patient experience in practically any care setting. In addition, Tryten provides customized cart solutions to medical device companies and healthcare solution providers so they can safely and effectively mobilize their technology devices for better clinical workflows and improved patient care delivery.
Tryten mobile computing carts are applicable for a host of applications including:
- Ultrasound
- Cardiology
- Endoscopy
- Tele Stroke
- Virtual Interpreting/translation
- Patient observation
- Electronic health records
- Patient registration and vital signs
“After observing the rapid adoption of virtual care and the expanded use of tablets and innovative technologies in healthcare, we decided that now was the right time to invest in expanding Capsa’s point-of-care solutions portfolio,” says Eric Webb, Capsa Healthcare CEO. “Tryten is a fresh, relatively new brand in the mobile workstation space, and we have every reason to believe its inclusion will help our clinical customers deliver the best care to patients in whatever setting they work.”
Understanding that computing workstation needs differ across care environments, Capsa Healthcare offers an extensive portfolio of mobile computing workstations, wall mount arm platforms, and solutions that support modern medication management. Capsa’s breadth of products include its Trio, M38e, MedLink, T7, and SlimCart mobile workstations, as well at its leading V6 wall mount solution. The addition of Tryten’s mobile carts is complementary to Capsa’s point-of-care solutions and opens a new and exciting opportunity to advance both virtual and patient-centered healthcare delivery.
“Tryten and Capsa have both worked diligently toward a similar overarching goal to improve the clinician’s ability to efficiently deliver quality care to the patient. Bringing the Tryten product line into Capsa’s portfolio is a natural fit culturally and functionally,” says Tony Janzen, Tryten CEO. “We’re excited for what the future holds as our team joins the expanding Capsa organization.”
AboutCapsaHealthcare
Capsa Healthcare is a worldwide leader in developing and delivering innovative healthcare solutions for a wide spectrum of care providers. With 60+ years of experience, Capsa Healthcare offers a unique ability to meet the demands of diverse healthcare environments and offers a broad range of products including medication carts, medical carts, mobile computing, and pharmacy automation solutions. Headquartered in Columbus, OH, and with a quickly growing global presence, Capsa Healthcare has 400+ employees with management, sales, and production offices throughout the world. To learn more visit www.capsahealthcare.comor call 800-437-6633.
AboutTryten
Tryten Technologies Inc., based in Langley, British Columbia, designs and manufactures lightweight, versatile mobile cart solutions for a wide range of applications including video remote interpreting (VRI), virtual rounding, tele sitting, EHR workstations, and telemedicine. Tryten’s goal is to improve the patient and provider experience while reducing the cost of care, enabling value-based care where and when it is needed most.
Press Contact:
Liz Delp
Senior Marketing Manager | Capsa Healthcare
Columbus, OH U.S.A.
614.729.8012 | ldelp@capsahealthcare.com
Photography Available
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab25.4.2024 04:11:25 CEST | Press release
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug Office, Department of Health, the Government of the Hong Kong Special Administrative Region (“DO”) has recently accepted the New Drug Application (“NDA”) for toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (“NPC”), and as a single agent for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy. The NDA is supported by results from JUPITER-02, a randomized, double-blind, placebo-controlled, multinational multi-center Phase 3 clinical study (NCT03581786) that examined toripalimab in combina
Net Income of R$ 55.3 mm in 1Q24, a 90.1% Increase YOY and Leases EBITDA Margin of 72.1%25.4.2024 02:58:18 CEST | Press release
On track to deliver 2024 Record Production of 500,000 sqm of GLA BELO HORIZONTE, Brazil, April 24, 2024 (GLOBE NEWSWIRE) -- Log Commercial Properties (B3: LOGG3), a leading developer of greenfield assets and lessor of Class A logistics warehouses in Brazil, is pleased to announce its financial results for the first quarter. 1Q24 Operational Highlights: Deliveries totaling 57,000 sqm of GLA were completed with a 100% pre-lease rateMilestone of 2.0 million sqm of GLA historically delivered by the CompanyGross absorption of 134,000 sqm of GLAStabilized vacancy of 0.91%,Same Client Rent of 1,9%, above inflation for the 7th consecutive quarter 1Q24 Financial Highlights: Strong EBITDA of R$ 74.0 million in 1Q24, with a growth of 36.4%EBITDA from leases of R$ 38.8 million and a margin of 72.1% in 1Q24Asset recycling of R$ 1.7 billion in the last 12 monthsAdjusted net debt reduction of 37.4%, totaling R$ 744.3 million in 1Q24Adjusted leverage of 0.8x considering the asset sales in April Manage
Elavon and FreedomPay to transform payments for hospitality and retail in Europe25.4.2024 01:01:00 CEST | Press release
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Elavon, a leading global payments provider, today announces its expanded collaboration in Europe with FreedomPay, a global leader in Next Level Commerce™ technologies. The partnership aims to deliver cutting-edge integrated commerce solutions and omni-channel payments technology to large enterprise merchants across Retail and Hospitality. The agreement pairs Elavon acquiring with FreedomPay commerce technologies to benefit Elavon merchants across Europe, empowering businesses with enhanced payment flexibility and optionality, data security, and a seamlessly integrated payments technology across both physical and ecommerce channels. “Elavon and FreedomPay have an enviable track record in Europe of helping hospitality and retail merchants grow their operations and better meet their customers’ needs,” said Hemlata Narasimhan, President of Elavon in Europe. “We’re pleased to extend our relationship with FreedomPay to continue to offer the first-cl
Ensurge Micropower ASA - Grant of Incentive Subscription Rights24.4.2024 23:30:00 CEST | Press release
The Board of Directors of Ensurge Micropower ASA (the "Company") resolved on 24 April 2024 to issue a total of 202,200 incentive subscription rights to employees in the Ensurge group. The grants were made under the Company's 2023 incentive subscription rights plan, as resolved at the Annual General Meeting on 24 May 2023, and amended on the Extraordinary General Meeting held on 10 November 2023. The exercise price of the subscription rights is calculated to NOK 1.2640 per share. The subscription rights expire on 24 May 2028. The subscription rights follow the terms and conditions of the 2023 subscription rights incentive plan. Following the grant there are 46,057,881 incentive subscription rights issued and outstanding in the Company. For more information, please contact: Lars Eikeland, Chief Executive Officer E- mail: lars.eikeland@ensurge.com This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Bombardier Unveils Bold New Brand Identity Worldwide as Company Soars Toward an Ambitious Future24.4.2024 23:12:07 CEST | Press release
A new logo celebrates the company’s successful shift toward pure-play business aviation. The symbol itself, the Bombardier Mach, features the silhouette of an aircraft breaking the sound barrier, while the strokes of wind over a wing reference the company’s heritageThe employee value proposition “where heart meets mastery” focuses on Bombardier’s talented people, celebrating the workforce’s renowned passion, its incredible craftsmanship and profound technological expertise MONTRÉAL, April 24, 2024 (GLOBE NEWSWIRE) -- Bombardier, the worldwide leader in business aviation, today unveiled a new brand identity anchored by the evolution of the company’s logo. As Bombardier successfully moves forward as a company with a sole focus on designing, building and servicing the world’s best business jets, the new brand identity will reinforce and propel the company’s unique approach to its customers and stakeholders—putting people at the centre and instilling a one-of-a-kind sense of family. Bombar